Many multiple sclerosis patients have reported severe side effects after being switched from the drug Tysabri to a cheaper alternative, Tyruko, in an NHS money-saving initiative. At Charing Cross hospital alone, approximately 170 patients suffered complications, including relapses, mobility issues, fatigue, and significant weight gain. Reports suggest these side effects may not be limited to one hospital, as patients indicate similar experiences across 15 other facilities. NHS England, looking to save £1 billion over five years on off-patent medications, is currently in talks with health authorities regarding the safety of Tyruko. The outcome of these discussions is urgently awaited by patients and healthcare professionals alike.
Scores of people with multiple sclerosis have suffered debilitating side-effects after being put on a cheaper new drug as part of an NHS drive to save money.
Approximately 170 MS patients at Charing Cross hospital have experienced complications after being switched from Tysabri to Tyruko, resulting in severe, sometimes hospitalizing symptoms.
Collection
[
|
...
]